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This multidisciplinary workshop offered an
opportunity to appraise the signiﬁcant progress
made in the past 5 years towards improving the
preparedness of Europe to respond to the threats
of emerging infections, antibiotic resistance and
bioterrorism, strengthening the training of infec-
tion specialists and delivering adequate infection
diagnosis, treatment and prevention services. At
the same time, it was agreed that much effort
must be made to address these health threats
adequately. To this end, several recommendations
were agreed upon by the Workshop participants.
Addressing the public health challenges, it was
stressed that more studies are urgently needed to
measure the health and economic burden of
nosocomial infections and antibiotic resistance.
Epidemiological surveillance systems require crit-
ical review as to the health gains they provide,
their ﬂexibility in detecting and analysing emer-
ging threats and their utility for guiding health
policy. International benchmarking of national
and regional surveillance systems should be
undertaken. Involvement of service providers
across the spectrum of medical care in surveil-
lance and alert networks is desirable and requires
broader training efforts of health professionals.
The European Centre for Disease Control and
Prevention will have a crucial role in achieving
better-coordinated surveillance and prevention of
infection. To accomplish its mission, it will need
strong support from professionals to foster a
culture of information-sharing and harmonised
responses to communicable disease, as well as
greater funding to develop a credible workforce
and technical capacity. There should be closer
working relationships between infection disci-
plines and public health entities at all levels.
Within Europe, the changing needs for infec-
tion management in healthcare systems have led
to the development of various models for diag-
nostic laboratories, clinical infectious disease ser-
vices and public health programmes. This
diversity poses a major problem in building
integrated and international surveillance, alert
and response systems. Standardisation of meth-
ods, laboratory accreditation and quality assur-
ance are ways to improve consistency and
reliability. Another advance is the closer scientiﬁc
and professional collaboration that enables the
convergence of expertise in Europe. Technological
advances in laboratory diagnosis and electronic
communication provide novel opportunities for
improved patient management that must be
carefully assessed by cost-effectiveness and cost–
beneﬁt analyses.
Several threats to optimal service were identi-
ﬁed. As well as increasing healthcare costs,
technological advances drive the centralisation
of laboratory services, which could jeopardise the
necessary interaction between microbiologists
and clinicians. Many countries suffer from an
ageing workforce and shortage of infection spe-
cialists, a combination that might undermine
current efforts to improve disease management
and control. Career options for young physicians
must be improved, to recruit new talent in the
infection disciplines.
The workshop participants strongly supported
the participation of the clinical microbiologists in
clinical ward rounds and their advisory role for
diagnostic and therapeutic issues. They also
considered that microbiologists have a deﬁnite
role to play in infection control, drugs and
therapeutics, antibiotic policy and biosafety com-
mittees. There was consensus that the expertise
of microbiologists, and infectious disease and
infection control specialists, must be better
integrated to form operational teams, in a
manner that varies according to the speciﬁc
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needs and histories of different healthcare sys-
tems.
There were conﬂicting views concerning (1) the
microbiologist’s managerial responsibilities for
running the laboratory, (2) the degree to which
expensive equipment and core facilities should be
shared with other laboratory disciplines, and (3)
the optimal number of clinical microbiologists,
infection control specialists and infectious disease
specialists for a 1000-bed hospital. It was sugges-
ted that a working party be established to further
investigate the current arrangements in Europe
and develop recommendations for the optimal
organisation of infection services.
The workshop considered the best options for
training and continuing professional development
of infection specialists. The current core training
programmes developed by the respective Euro-
peanUnion ofMedical Specialists (UEMS) Sections
for Infectious Diseases and Medical Biopathology,
Microbiology Commission was considered gener-
ally adequate in view of the disparity among
European medical healthcare systems. Core com-
petence must be comprehensive and apply to all
types of infections, andmust include introductions
to epidemiology andpublic health approaches. The
subject of infection control should have its own
training curriculum. In countries where it is not
recognised as a specialty, this curriculumshouldbe
incorporated into or complement that for micro-
biology and ⁄ or infectious diseases. A core curricu-
lum for a single specialty of infection medicine
should be considered, to better integrate all infec-
tion disciplines. After common training, various
degrees of sub-specialisation should be offered in
medical microbiology, infectious diseases, paedi-
atric infectious diseases and infection control.
To warrant free movement of specialists and
ensure equivalent quality of care across Europe,
core curricula should be similar in all member
states. The implementation and validation of
training programmes vary considerably among
European Union member states. Research in the
assessment methodology for specialty training
and competence (re)certiﬁcation should be sup-
ported. Validation of training centres and training
programmes should remain national, but these
should adhere to European recommendations.
It should be possible to collect continuing
medical education credits at the national and
international levels. To simplify and harmonise
continuing medical education accreditation, the
UEMS Specialist Sections should be empowered
to accredit European and international events.
Finally, it was agreed that the ESCMID has an
important role to play in bridging the gap
between professionals from public health, clinical
and laboratory medicine, as well as in raising
public awareness about the threat posed by
infectious diseases through liaison with the
media. The ESCMID should remain a partner in
deﬁning the health targets and in developing
models of best practice. It should expand and
evaluate its educational activities to meet the
needs of all professionals involved in providing
health care services. Furthermore, the ESCMID
should provide a platform for the interaction of
key players in academia, healthcare practice,
industry, regulatory and public health agencies,
and national and European organisations.
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